Word

HAVBEQ

Status

Pending

Status Code

688

Status Date

Tuesday, January 23, 2024

Serial Number

97771229

Mark Type

4000

Filing Date

Friday, January 27, 2023

Published for Opposition

Tuesday, November 28, 2023

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events

Jan 23, 2024

Noa E-Mailed - Sou Required From Applicant

Nov 28, 2023

Official Gazette Publication Confirmation E-Mailed

Nov 28, 2023

Published For Opposition

Nov 8, 2023

Notification Of Notice Of Publication E-Mailed

Oct 26, 2023

Approved For Pub - Principal Register

Oct 25, 2023

Assigned To Examiner

Feb 15, 2023

New Application Office Supplied Data Entered

Jan 31, 2023

New Application Entered